logo
  •   Home
  • Applications
    • Indications
  • Business
  • EpiSwitch®
  • Products
    • EpiSwitch® Explorer Kit
    • EpiSwitch ® Service
  • Investors
    • Investors Overview
    • Results and Presentations
    • Share Price Information
    • Regulatory News
    • Board & Governance
    • Key Corporate Documents
    • AIM Rule 26
    • Email Alerts
    • Investor Contacts
  • News
  • About Us
    • History
    • Board of Directors
    • Management Team
    • Scientific Advisory Panel
    • Values
    • Careers

Events

CEO presentation on OBD’s expanded strategic focus

Video Link

by oxfordbiodynamics

Oxford BioDynamics to expand strategic focus

Press Release

by oxfordbiodynamics

Strategic partnership with Boca Biolistics

Press Release

by oxfordbiodynamics

Disease severity program for COVID-19 advances

Press Release

by oxfordbiodynamics

Oxford BioDynamics biomarker platform is selected to help identify COVID-19 patients at risk of severe disease and profile patients who will benefit from therapeutic treatment

Press Release

by oxfordbiodynamics

Board restructure to support future growth

Press Release

by oxfordbiodynamics

Oxford BioDynamics to present at BioTech Pharma Summit: Liquid Biopsy 2020 in Lisbon, Portugal

Press Release

by oxfordbiodynamics

Final Results for year ended 30 September 2019

Press Release

by oxfordbiodynamics

Oxford BioDynamics’ EpiSwitch™ Featured in Presentations on Development and Validation of Blood-Based Predictive Biomarkers in Immune Checkpoint Inhibitor Programs

Journal articles P142

Journal articles P143

Press Release

Links to top articles -

Chase

Seeking Alpha

MarketWatch

MorningStar

PR Newswire

Associated Press

Finanzen.net

Yahoo! Finance

Daily Herald

Buffalo News

 

by oxfordbiodynamics

Oxford BioDynamics notes first patient enrolled in ALS biomarker study sponsored by Mitsubishi Tanabe Pharma America

Press Release

by oxfordbiodynamics

  • 1
  • 2
  • 3
  • 4

Terms of Use / Site Map / Privacy Policy / Cookies Policy

Regulated and Licensed by Human Tissue Authority
License No. 12571
© 2002-2020 Oxford Biodynamics Plc

Privacy Preference Center

Privacy Preferences